Joined July 2010
1,222 Photos and videos
World Orphan Drug Congress USA retweeted
Ever heard of #HSPB8 #Myopathy (MFM13)? Probably not. Check out our poster from the @OrphanConf and if you're feeling bold, pass it on.
1
3
3
216
World Orphan Drug Congress USA retweeted
Our COO, Karen Tubridy, participated in a panel at @OrphanConf on women redefining healthcare, discussing topics including overcoming barriers in the healthcare industry and creating impactful solutions in rare diseases. #WorldOrphanUSA
2
1
3
195
RT @X4Pharma: Our VP of Sales & Marketing recently hosted a fireside chat with Medical Publisher @CheckRare at #WorldOrphanUSA, a forum focโ€ฆ
4
Last week, we wrapped up #WorldOrphanUSA 2025 โ€“ our largest and most impactful edition to date! ๐ŸŒŸ ๐ŸŒŸ Our team wants to give a huge THANK YOU to our sponsors, exhibitors, speakers, and attendees for making this yearโ€™s event unforgettable. Your passion, insights, and commitment to the rare disease community have fueled every conversation, every connection, and every breakthrough moment. Together, weโ€™re not just talking about change โ€“ we're making it happen. We can't wait to see the impact youโ€™ll carry forward from here! โค๏ธโ€๐Ÿฉน ๐˜‹๐˜ช๐˜ฅ ๐˜บ๐˜ฐ๐˜ถ ๐˜ฉ๐˜ฆ๐˜ข๐˜ณ? We're returning to Boston for our 2026 edition... ๐Ÿ‘‡ ๐’๐€๐•๐„ ๐“๐‡๐„ ๐ƒ๐€๐“๐„ ๐Ÿ—“๏ธ May 19-21, 2026 ๐Ÿ“ Boston Convention & Exhibition Center Stay tuned for more on next year's event โ€“ we can't wait to see you back in Boston for another amazing year!
1
2
128
World Orphan Drug Congress USA retweeted
28 Apr 2025
Thanks to Terrapin for another successful World Orphan Drug Congress USA! We look forward to our continued partnership with this outstanding team. #WorldOrphanUSA #Terrapin #Checkrare @OrphanConf
1
1
3
118
World Orphan Drug Congress USA retweeted
#WorldOrphanUSA: โ€œThe delay of MLD screening equals death for these babies. They cannot wait.โ€ - Christina Hartman, senior director of government affairs at @orchard_tx, whose #GeneTherapy treats metachromatic leukodystrophy (MLD). #RDAatWODC @OrphanConf
2
2
212
World Orphan Drug Congress USA retweeted
I am exhausted but empowered after the last few days at the @OrphanConf in Boston, especially after today's panel with fellow rare disease advocates @Jeanc9orf72, Allison Peck, and Heidi Edwards, as well as the woman who brought us all together...
2
1
5
144
World Orphan Drug Congress USA retweeted
Day 2 at #WODCUSA is all about the power of partnershipsโ€”patient advocacy, storytelling, and building community. Itโ€™s inspiring to see how these voices shape progress in rare disease care. What insights have stood out most to you today? @OrphanConf #WorldOrphanUSA #RareDisease
1
2
63
World Orphan Drug Congress USA retweeted
We out here repping @APSType1 and Rare Disease International at the @orphanconf #worldorphandrugcongress
1
1
78
World Orphan Drug Congress USA retweeted
24 Apr 2025
We're at @OrphanConf this week to support our clients and participate in important conversations for rare diseases. We're proud to be a part of the progress.
1
1
61
World Orphan Drug Congress USA retweeted
#WorldOrphanUSA: Jennifer McNary, CEO of Canary Advisors, speaking April 23, 2025, at @OrphanConf. @LLuxner #RDAatWODC
2
2
190
World Orphan Drug Congress USA retweeted
Thatโ€™s a wrap on the 2025 @OrphanConf! SMPA was honored to contribute alongside researchers, clinicians and advocates dedicated to advancing rare disease research. #WorldOrphanUSA #RareDisease
1
1
118
World Orphan Drug Congress USA retweeted
1
1
113
World Orphan Drug Congress USA retweeted
#WorldOrphanUSA: "Everyone is not their diagnosisโ€ฆ& we clinicians canโ€™t assume that because we see the world & their disease a certain way, thatโ€™s the way they want to see it." - Dr.ย Faisal Riaz,ย Neuroimmunologyย & AATD specialist at Takeda Pharmaceutical." @OrphanConf
1
2
135
Good morning from Boston! Day 2 of #WorldOrphanUSA 2025 is underway ๐ŸŒŸ After an incredible first day packed with insight, energy, and collaboration, weโ€™re diving into another full day of advancing the future of #OrphanDrug development and #raredisease care. Weโ€™re starting strong with todayโ€™s main stage keynote sessions, featuring thought leaders who are challenging norms, shaping policy, and pushing innovation forward โ€“ including โ†ด [8:30AM] ๐˜Š๐˜ฉ๐˜ข๐˜ช๐˜ณ ๐˜ฑ๐˜ฆ๐˜ณ๐˜ด๐˜ฐ๐˜ฏ ๐˜ฐ๐˜ฑ๐˜ฆ๐˜ฏ๐˜ช๐˜ฏ๐˜จ ๐˜ณ๐˜ฆ๐˜ฎ๐˜ข๐˜ณ๐˜ฌ๐˜ด | ๐“๐ซ๐š๐ง๐ฌ๐Ÿ๐จ๐ซ๐ฆ๐ข๐ง๐  ๐ญ๐ก๐ž ๐๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ ๐š๐ง๐ ๐ซ๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ ๐ฅ๐š๐ง๐๐ฌ๐œ๐š๐ฉ๐ž ๐ญ๐จ ๐ฆ๐ž๐ž๐ญ ๐ญ๐ก๐ž ๐ง๐ž๐ž๐๐ฌ ๐จ๐Ÿ ๐ฎ๐ง๐ญ๐ซ๐ž๐š๐ญ๐ž๐ ๐ซ๐š๐ซ๐ž ๐๐ข๐ฌ๐ž๐š๐ฌ๐ž๐ฌ ๐ข๐ง ๐ญ๐ก๐ž ๐Ÿ๐Ÿ๐ฌ๐ญ ๐œ๐ž๐ง๐ญ๐ฎ๐ซ๐ฒ โœฎ CEO, @ultragenyx [8:50AM] ๐˜’๐˜ฆ๐˜บ๐˜ฏ๐˜ฐ๐˜ต๐˜ฆ ๐˜—๐˜ข๐˜ฏ๐˜ฆ๐˜ญ | ๐๐ซ๐ข๐จ๐ซ๐ข๐ญ๐ข๐ž๐ฌ, ๐ฉ๐จ๐ฅ๐ข๐œ๐ข๐ž๐ฌ ๐š๐ง๐ ๐ข๐ฆ๐ฉ๐š๐œ๐ญ ๐จ๐ง ๐ฉ๐š๐ญ๐ข๐ž๐ง๐ญ๐ฌ ๐ฅ๐ข๐ฏ๐ข๐ง๐  ๐ฐ๐ข๐ญ๐ก ๐‘๐š๐ซ๐ž ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž โœฎ Moderator: Partner, Health Policy Strategies โœฎ Chief Global Value and Access Officer, @JNJInnovMed โœฎ President, Co-Founder, @CureFA_org โœฎ Director of Policy and Regulatory Affairs, @RareDiseases (NORD) ๐˜š๐˜ฑ๐˜ฐ๐˜ฏ๐˜ด๐˜ฐ๐˜ณ๐˜ฆ๐˜ฅ ๐˜ฃ๐˜บ @JNJNews [9:30AM] ๐˜’๐˜ฆ๐˜บ๐˜ฏ๐˜ฐ๐˜ต๐˜ฆ ๐˜—๐˜ข๐˜ฏ๐˜ฆ๐˜ญ | ๐๐ฎ๐ข๐ฅ๐๐ข๐ง๐  ๐ญ๐ก๐ž ๐Ÿ๐ซ๐š๐ฆ๐ž๐ฐ๐จ๐ซ๐ค: ๐€ ๐ฌ๐ฎ๐ฌ๐ญ๐š๐ข๐ง๐š๐›๐ฅ๐ž, ๐ž๐Ÿ๐Ÿ๐ž๐œ๐ญ๐ข๐ฏ๐ž, ๐š๐ง๐ ๐ž๐ช๐ฎ๐ข๐ญ๐š๐›๐ฅ๐ž ๐ฌ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐Ÿ๐จ๐ซ ๐Ž๐ซ๐ฉ๐ก๐š๐ง ๐ƒ๐ซ๐ฎ๐ ๐ฌ โœฎ Moderator: EVP, Chief Medical Officer, @ultragenyx โœฎ President, Head of R&D and COO, Rocket Phama โœฎ CEO, @alliancerm [12:50PM] ๐˜’๐˜ฆ๐˜บ๐˜ฏ๐˜ฐ๐˜ต๐˜ฆ ๐˜—๐˜ข๐˜ฏ๐˜ฆ๐˜ญ & ๐˜š๐˜ค๐˜ณ๐˜ฆ๐˜ฆ๐˜ฏ๐˜ช๐˜ฏ๐˜จ | ๐“๐ก๐ž ๐๐ž๐ฑ๐ญ ๐…๐ซ๐จ๐ง๐ญ๐ข๐ž๐ซ: ๐“๐ก๐ž ๐š๐ซ๐ญ ๐จ๐Ÿ ๐ข๐ฆ๐ฉ๐š๐œ๐ญ๐Ÿ๐ฎ๐ฅ ๐ฌ๐ญ๐จ๐ซ๐ฒ๐ญ๐ž๐ฅ๐ฅ๐ข๐ง๐  ๐ข๐ง ๐‘๐š๐ซ๐ž ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž โœฎ Moderator: Global VP of Programme Partnerships, @BBCStoryWorks โœฎChief Patient Advocate & Head, Patient Advocacy Center of Excellence, @IAmBiotech (BIO) โœฎ Global Head of Clinical Development and General Manager, Europe & USA, JCR Pharmaceuticals โœฎ Director Of Development, Programme Partnerships, @BBC There's still time to join us today in Boston! ๐Ÿ‘‰ Register below & get ready for bold ideas, honest dialogue, and the kind of connections that fuel long-term impact. terrapinn.com/bookwodc_tw
1
1
4
126
World Orphan Drug Congress USA retweeted
Rare Disease Advisor is in Boston, MA for #WorldOrphanUSA. Follow along for live updates, expert interviews, and our first-ever Rare Advocacy session! @OrphanConf #RDAatWODC
3
6
181
๐Ÿฅ ๐˜‹๐˜ณ๐˜ถ๐˜ฎ ๐˜ณ๐˜ฐ๐˜ญ๐˜ญ ๐˜ฑ๐˜ญ๐˜ฆ๐˜ข๐˜ด๐˜ฆ... Day 1 of the World Orphan Drug Congress USA 2025 is finally here! The #raredisease community is taking over Boston this week, and weโ€™re kicking things off with a powerhouse lineup of visionary keynote sessions setting the tone for the days ahead. This morning, weโ€™re diving into the most critical conversations shaping the future of the rare disease space โ†ด [8:25am] ๐˜–๐˜ฑ๐˜ฆ๐˜ฏ๐˜ช๐˜ฏ๐˜จ ๐˜ณ๐˜ฆ๐˜ฎ๐˜ข๐˜ณ๐˜ฌ๐˜ด | ๐“๐จ๐๐š๐ฒโ€™๐ฌ ๐ฉ๐จ๐ฅ๐ข๐œ๐ข๐ž๐ฌ ๐ฐ๐ข๐ฅ๐ฅ ๐ฆ๐š๐ค๐ž ๐จ๐ซ ๐›๐ซ๐ž๐š๐ค ๐ญ๐จ๐ฆ๐จ๐ซ๐ซ๐จ๐ฐโ€™๐ฌ ๐‘๐š๐ซ๐ž ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž ๐ฉ๐ข๐ฉ๐ž๐ฅ๐ข๐ง๐ž๐ฌ โœบ Chief Patient Advocate & Head, Patient Advocacy Center of Excellence, @IAmBiotech (BIO) [8:45am] ๐˜’๐˜ฆ๐˜บ๐˜ฏ๐˜ฐ๐˜ต๐˜ฆ ๐˜—๐˜ข๐˜ฏ๐˜ฆ๐˜ญ | ๐„๐š๐ซ๐ฅ๐ฒ ๐ข๐ง๐ญ๐ž๐ซ๐ฏ๐ž๐ง๐ญ๐ข๐จ๐ง: ๐“๐ก๐ž ๐œ๐ซ๐ข๐ญ๐ข๐œ๐š๐ฅ ๐ฉ๐š๐ญ๐ก ๐ข๐ง ๐ซ๐š๐ซ๐ž ๐๐ข๐ฌ๐ž๐š๐ฌ๐ž๐ฌ โœบ Moderator: Health & Medical Reporter and Writer, @NBCNews โœบ General Manager, US Rare Disease, @Sanofi โœบ CEO, @RareDiseases (NORD) [9:05am] ๐˜’๐˜ฆ๐˜บ๐˜ฏ๐˜ฐ๐˜ต๐˜ฆ ๐˜—๐˜ข๐˜ฏ๐˜ฆ๐˜ญ | ๐‘๐ž๐ฉ๐จ๐ฌ๐ข๐ญ๐ข๐จ๐ง๐ข๐ง๐  ๐๐ฎ๐ ๐ฌ ๐Ÿ๐จ๐ซ ๐‘๐š๐ซ๐ž ๐ƒ๐ข๐ฌ๐ž๐š๐ฌ๐ž๐ฌ: ๐”๐ง๐ฅ๐ž๐š๐ฌ๐ก๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฉ๐จ๐ญ๐ž๐ง๐ญ๐ข๐š๐ฅ ๐จ๐Ÿ ๐ฌ๐ก๐ž๐ฅ๐ฏ๐ž๐ ๐š๐ฌ๐ฌ๐ž๐ญ๐ฌ ๐ข๐ง ๐ฉ๐ก๐š๐ซ๐ฆ๐š ๐š๐ง๐ ๐›๐ข๐จ๐ญ๐ž๐œ๐ก โœบ Moderator: CEO, @ChildrensTumor โœบ Former Chief Patient Officer & Executive Vice President, @pfizer โœบ Charles E. and Susan T. Harris Professor, @MITSloan โœบ Visiting Fellow, @DukeMargolis โœบ Associate Professor, Markets, Public Policy, and Law, @BU_Tweets [9:45am] ๐˜’๐˜ฆ๐˜บ๐˜ฏ๐˜ฐ๐˜ต๐˜ฆ ๐˜—๐˜ข๐˜ฏ๐˜ฆ๐˜ญ | ๐•๐ข๐ฌ๐ข๐จ๐ง ๐Ÿ๐ŸŽ๐Ÿ‘๐ŸŽ: ๐‚๐ก๐š๐ซ๐ญ๐ข๐ง๐  ๐š ๐›๐ซ๐ข๐ ๐ก๐ญ ๐Ÿ๐ฎ๐ญ๐ฎ๐ซ๐ž ๐Ÿ๐จ๐ซ ๐ซ๐š๐ซ๐ž ๐ฆ๐ž๐๐ข๐œ๐ข๐ง๐ž โœบ Moderator: Executive Director, Global Head of Rare Disease, CoE, @Parexel โœบ Director of Strategic Coalitions, Rare Disease Innovation Hub, @US_FDA โœบ Co-Founder, @CnryAdvisors โœบ SVP, Patient Affairs, @Sarepta โœบ CEO, @reaganudall There's still time to join the world's most important event for advancing Orphan Drug development and rare disease patient care. Act now ๐ŸŽŸ๏ธ Get your ticket today [๐˜ญ๐˜ช๐˜ฎ๐˜ช๐˜ต๐˜ฆ๐˜ฅ ๐˜ข๐˜ท๐˜ข๐˜ช๐˜ญ๐˜ข๐˜ฃ๐˜ช๐˜ญ๐˜ช๐˜ต๐˜บ] and join us in Boston today & tomorrow โžœ terrapinn.com/bookwodc_tw *๐˜—๐˜ข๐˜ต๐˜ช๐˜ฆ๐˜ฏ๐˜ต ๐˜ข๐˜ฅ๐˜ท๐˜ฐ๐˜ค๐˜ข๐˜ต๐˜ฆ๐˜ด ๐˜ข๐˜ฏ๐˜ฅ ๐˜ฉ๐˜ฐ๐˜ด๐˜ฑ๐˜ช๐˜ต๐˜ข๐˜ญ ๐˜ฑ๐˜ณ๐˜ข๐˜ค๐˜ต๐˜ช๐˜ต๐˜ช๐˜ฐ๐˜ฏ๐˜ฆ๐˜ณ๐˜ด ๐˜ข๐˜ต๐˜ต๐˜ฆ๐˜ฏ๐˜ฅ ๐˜ง๐˜ฐ๐˜ณ ๐˜๐˜™๐˜Œ๐˜Œ #WorldOrphanUSA ๐Ÿ—“๏ธ April 22-24 ๐Ÿ“ Boston Convention & Exhibition Center
2
4
184
๐Ÿ“ฃ Meet the Day 1 Chairs of #WorldOrphanUSA 2025! Tomorrow, these industry leaders are bringing their expertise, energy, and vision to the forefront โ€“ guiding the conversations that matter most in rare disease and orphan drug innovation. โœฆ ๐ˆ๐ง๐ง๐จ๐ฏ๐š๐ญ๐ข๐จ๐ง & ๐๐š๐ซ๐ญ๐ง๐ž๐ซ๐ฌ๐ก๐ข๐ฉ๐ฌ โ†’ VP, Head of US Medical Affairs, ITF Therapeutics LLC โœฆ ๐‚๐ฅ๐ข๐ง๐ข๐œ๐š๐ฅ ๐ƒ๐ž๐ฏ๐ž๐ฅ๐จ๐ฉ๐ฆ๐ž๐ง๐ญ & ๐‘๐ž๐ ๐ฎ๐ฅ๐š๐ญ๐จ๐ซ๐ฒ โ†’ Senior Director, Global Medical Affairs, @Alnylam โœฆ ๐‘๐š๐ซ๐ž ๐€๐๐ฏ๐จ๐œ๐š๐œ๐ฒ โ†’ Executive Director, @SistersHopeALSP โœฆ ๐€๐๐ฏ๐š๐ง๐œ๐ž๐ ๐“๐ก๐ž๐ซ๐š๐ฉ๐ข๐ž๐ฌ โ†’ VP, Medical Affairs, Rare Diseases and Pediatrics, @premierresearch โœฆ ๐‚๐จ๐ฆ๐ฆ๐ž๐ซ๐œ๐ข๐š๐ฅ โ†’ Managing Director, @HavasMediaGroup (Havas Life Rare) โœฆ ๐„๐š๐ซ๐ฅ๐ฒ ๐€๐œ๐œ๐ž๐ฌ๐ฌ ๐๐ซ๐จ๐ ๐ซ๐š๐ฆ๐ฌ โ†’ Director, Expanded Access Program, @argenxglobal โœฆ ๐€๐ˆ & ๐ƒ๐ข๐ ๐ข๐ญ๐š๐ฅ ๐‡๐ž๐š๐ฅ๐ญ๐ก โ†’ Rare Disease Patient Digital Technology Advisor, Bartlett Rare Disease Advocacy Join these industry leaders this week in Boston as they drive the dialogue shaping the future of rare and orphan drug development โ€“ from clinical breakthroughs to commercialization and policy. There's still time to register! ๐ŸŽŸ๏ธ๐˜š๐˜ฆ๐˜ค๐˜ถ๐˜ณ๐˜ฆ ๐˜บ๐˜ฐ๐˜ถ๐˜ณ ๐˜ด๐˜ฑ๐˜ฐ๐˜ต ๐˜ฃ๐˜ฆ๐˜ญ๐˜ฐ๐˜ธ ๐˜ฃ๐˜ฆ๐˜ง๐˜ฐ๐˜ณ๐˜ฆ ๐˜ต๐˜ช๐˜ค๐˜ฌ๐˜ฆ๐˜ต๐˜ด ๐˜ด๐˜ฆ๐˜ญ๐˜ญ ๐˜ฐ๐˜ถ๐˜ต: ๐Ÿ”ฌ ๐˜—๐˜ฉ๐˜ข๐˜ณ๐˜ฎ๐˜ข ๐˜ข๐˜ฏ๐˜ฅ ๐˜ฃ๐˜ช๐˜ฐ๐˜ต๐˜ฆ๐˜ค๐˜ฉ๐˜ด โ€“ register now and get ๐ฌ๐ฉ๐ž๐œ๐ข๐š๐ฅ ๐ญ๐ข๐œ๐ค๐ž๐ญ ๐ฉ๐ซ๐ข๐œ๐ข๐ง๐ : terrapinn.com/bookwodc_tw ๐Ÿฅ ๐˜—๐˜ข๐˜ต๐˜ช๐˜ฆ๐˜ฏ๐˜ต ๐˜ข๐˜ฅ๐˜ท๐˜ฐ๐˜ค๐˜ข๐˜ต๐˜ฆ๐˜ด ๐˜ข๐˜ฏ๐˜ฅ ๐˜ฉ๐˜ฐ๐˜ด๐˜ฑ๐˜ช๐˜ต๐˜ข๐˜ญ ๐˜ฑ๐˜ณ๐˜ข๐˜ค๐˜ต๐˜ช๐˜ต๐˜ช๐˜ฐ๐˜ฏ๐˜ฆ๐˜ณ๐˜ด โ€“ secure one of the last remaining free VIP passes: terrapinn.com/bookwodc_tw ๐Ÿ‘ฅ Save BIG with our discounted group rates and bring your team: terrapinn.com/freewodc_tw Pre-Conference Day: April 22 Event Day 1: April 23 Event Day 2: April 24 Venue: Boston Convention & Exhibition Center
1
2
120
Don't miss any highlights from #WorldOrphanUSA 2025! Follow our LinkedIn page below to catch LIVE coverage the next 3 days in Boston ๐Ÿ“ธ linkedin.com/company/world-oโ€ฆ ๐Ÿ—“๏ธ April 22-24 ๐Ÿ“ Boston Convention & Exhibition Cetner

2
2
102
๐˜›๐˜ฉ๐˜ฆ ๐˜ธ๐˜ข๐˜ช๐˜ต ๐˜ช๐˜ด ๐˜ง๐˜ช๐˜ฏ๐˜ข๐˜ญ๐˜ญ๐˜บ ๐˜ฐ๐˜ท๐˜ฆ๐˜ณ... #WorldOrphanUSA 2025 kicks off today with our Pre-Conference Day! ๐ŸŽŠ With a jam packed schedule filled with interactive workshops, presentations, and fireside chats , you won't want to miss this. Take a glimpse into what's in store โ†ด [1pm] Workshop | ๐˜‰๐˜ณ๐˜ฆ๐˜ข๐˜ฌ๐˜ช๐˜ฏ๐˜จ ๐˜ช๐˜ฏ๐˜ต๐˜ฐ ๐˜Œ๐˜ถ๐˜ณ๐˜ฐ๐˜ฑ๐˜ฆ: ๐˜—๐˜ข๐˜ณ๐˜ต๐˜ฏ๐˜ฆ๐˜ณ๐˜ด๐˜ฉ๐˜ช๐˜ฑ๐˜ด ๐˜ต๐˜ฉ๐˜ข๐˜ต ๐˜ฑ๐˜ณ๐˜ฐ๐˜ฑ๐˜ฆ๐˜ญ ๐˜œ.๐˜š. ๐˜ฃ๐˜ช๐˜ฐ๐˜ต๐˜ฆ๐˜ค๐˜ฉ๐˜ด ๐˜ต๐˜ฐ ๐˜ฐ๐˜ณ๐˜ฑ๐˜ฉ๐˜ข๐˜ฏ ๐˜ฅ๐˜ณ๐˜ถ๐˜จ ๐˜ด๐˜ถ๐˜ค๐˜ค๐˜ฆ๐˜ด๐˜ด โœด๏ธŽ VP Access & Reimbursement,ย @Sciensus_Group โœด๏ธŽ Director of Rare Clinical Services,ย @Sciensus_Group โœด๏ธŽ VP, Medical Affairs,ย @Sciensus_Group โœด๏ธŽ VP, Rare & Orphan Strategy,ย @Sciensus_Group โœด๏ธŽ SVP Commercial Strategy & Operations,ย @sentynl โœด๏ธŽ Volunteer,ย Rare Disease Patient *๐˜š๐˜ฑ๐˜ฐ๐˜ฏ๐˜ด๐˜ฐ๐˜ณ๐˜ฆ๐˜ฅ ๐˜ฃ๐˜บ ๐˜š๐˜ค๐˜ช๐˜ฆ๐˜ฏ๐˜ด๐˜ถ๐˜ด [2pm] Workshop | ๐˜›๐˜ฉ๐˜ฆ ๐˜ค๐˜ฐ๐˜ฎ๐˜ฎ๐˜ฆ๐˜ณ๐˜ค๐˜ช๐˜ข๐˜ญ ๐˜ง๐˜ฐ๐˜ณ๐˜ฆ๐˜ค๐˜ข๐˜ด๐˜ต ๐˜ข๐˜ด ๐˜ข ๐˜ด๐˜ต๐˜ณ๐˜ข๐˜ต๐˜ฆ๐˜จ๐˜บ-๐˜ฅ๐˜ณ๐˜ช๐˜ท๐˜ฆ๐˜ณ โœด๏ธŽ Director,ย @BluePrintOrphan โœด๏ธŽ President,ย @BluePrintOrphan *๐˜š๐˜ฑ๐˜ฐ๐˜ฏ๐˜ด๐˜ฐ๐˜ณ๐˜ฆ๐˜ฅ ๐˜ฃ๐˜บ ๐˜‰๐˜ญ๐˜ถ๐˜ฆ๐˜—๐˜ณ๐˜ช๐˜ฏ๐˜ต๐˜–๐˜ณ๐˜ฑ๐˜ฉ๐˜ข๐˜ฏ [2pm] Presentation | Access & Pricing | ๐˜•๐˜ข๐˜ท๐˜ช๐˜จ๐˜ข๐˜ต๐˜ช๐˜ฏ๐˜จ ๐˜ต๐˜ฉ๐˜ฆ ๐˜ค๐˜ฐ๐˜ฎ๐˜ฑ๐˜ญ๐˜ฆ๐˜น๐˜ช๐˜ต๐˜ช๐˜ฆ๐˜ด ๐˜ฐ๐˜ง ๐˜ข๐˜ค๐˜ค๐˜ฆ๐˜ด๐˜ด๐˜ช๐˜ฏ๐˜จ ๐˜ฆ๐˜ฎ๐˜ฆ๐˜ณ๐˜จ๐˜ช๐˜ฏ๐˜จ ๐˜ต๐˜ฉ๐˜ฆ๐˜ณ๐˜ข๐˜ฑ๐˜ช๐˜ฆ๐˜ด ๐˜ข๐˜ค๐˜ณ๐˜ฐ๐˜ด๐˜ด ๐˜ด๐˜ต๐˜ข๐˜ต๐˜ฆ ๐˜ฃ๐˜ฐ๐˜ณ๐˜ฅ๐˜ฆ๐˜ณ๐˜ด โœด๏ธŽ RN, Vice President - Emerging Discoveries,ย @BostonChildrens [3pm] Presentation | Patient Data | ๐˜๐˜ญ๐˜ญ๐˜ถ๐˜ฎ๐˜ช๐˜ฏ๐˜ข๐˜ต๐˜ช๐˜ฏ๐˜จ ๐˜ถ๐˜ญ๐˜ต๐˜ณ๐˜ข-๐˜ณ๐˜ข๐˜ณ๐˜ฆ ๐˜ฅ๐˜ช๐˜ด๐˜ฆ๐˜ข๐˜ด๐˜ฆ ๐˜ซ๐˜ฐ๐˜ถ๐˜ณ๐˜ฏ๐˜ฆ๐˜บ๐˜ด: ๐˜๐˜ข๐˜ณ๐˜ฏ๐˜ฆ๐˜ด๐˜ด๐˜ช๐˜ฏ๐˜จ ๐˜ณ๐˜ฆ๐˜ข๐˜ญ-๐˜ธ๐˜ฐ๐˜ณ๐˜ญ๐˜ฅ ๐˜ฅ๐˜ข๐˜ต๐˜ข ๐˜ข๐˜ฏ๐˜ฅ ๐˜ข๐˜ฅ๐˜ท๐˜ข๐˜ฏ๐˜ค๐˜ฆ๐˜ฅ ๐˜ข๐˜ฏ๐˜ข๐˜ญ๐˜บ๐˜ต๐˜ช๐˜ค๐˜ด ๐˜ต๐˜ฐ ๐˜ช๐˜ฅ๐˜ฆ๐˜ฏ๐˜ต๐˜ช๐˜ง๐˜บ ๐˜ต๐˜ฉ๐˜ฆ ๐˜ถ๐˜ฏ๐˜ฅ๐˜ช๐˜ข๐˜จ๐˜ฏ๐˜ฐ๐˜ด๐˜ฆ๐˜ฅ โœด๏ธŽ President,ย @Egetis_EGTX [3:20pm] Presentation | Next Gen Therapies | ๐˜”๐˜ฐ๐˜ฅ๐˜ฆ๐˜ญ๐˜ช๐˜ฏ๐˜จ ๐˜ข๐˜ฏ๐˜ฅ ๐˜š๐˜ช๐˜ฎ๐˜ถ๐˜ญ๐˜ข๐˜ต๐˜ช๐˜ฐ๐˜ฏ (๐˜”&๐˜š) ๐˜ช๐˜ฏ ๐˜ฏ๐˜ฆ๐˜น๐˜ต-๐˜จ๐˜ฆ๐˜ฏ ๐˜ต๐˜ฉ๐˜ฆ๐˜ณ๐˜ข๐˜ฑ๐˜ช๐˜ฆ๐˜ด: ๐˜ˆ๐˜ค๐˜ค๐˜ฆ๐˜ญ๐˜ฆ๐˜ณ๐˜ข๐˜ต๐˜ช๐˜ฏ๐˜จ ๐˜ช๐˜ฏ๐˜ฏ๐˜ฐ๐˜ท๐˜ข๐˜ต๐˜ช๐˜ฐ๐˜ฏ ๐˜ต๐˜ฉ๐˜ณ๐˜ฐ๐˜ถ๐˜จ๐˜ฉ ๐˜ช๐˜ฏ๐˜ด๐˜ช๐˜จ๐˜ฉ๐˜ต โœด๏ธŽ Chief Clinical Development Officer,ย @Polaryx777 Interested in being a part of the world's most important Orphan Drug and rare disease event? Good news โ€“ ๐ญ๐ก๐ž๐ซ๐ž'๐ฌ ๐ฌ๐ญ๐ข๐ฅ๐ฅ ๐ญ๐ข๐ฆ๐ž ๐ญ๐จ ๐ซ๐ž๐ ๐ข๐ฌ๐ญ๐ž๐ซ! ๐ŸŽŸ๏ธ Get your ticket below โ†ด โญ๏ธ ๐’๐ž๐œ๐ฎ๐ซ๐ž ๐จ๐ง๐ž ๐จ๐Ÿ ๐จ๐ฎ๐ซ ๐ฅ๐š๐ฌ๐ญ ๐š๐ฏ๐š๐ข๐ฅ๐š๐›๐ฅ๐ž ๐ญ๐ข๐œ๐ค๐ž๐ญ๐ฌ: terrapinn.com/bookwodc_tw โญ๏ธ Patient advocates & hospital practitioners, we've ๐š๐๐๐ž๐ ๐Ÿ“๐ŸŽ ๐ฆ๐จ๐ซ๐ž ๐œ๐จ๐ฆ๐ฉ๐ฅ๐ข๐ฆ๐ž๐ง๐ญ๐š๐ซ๐ฒ ๐•๐ˆ๐ ๐ฉ๐š๐ฌ๐ฌ๐ž๐ฌ for the first individuals that apply. Get yours now: terrapinn.com/freewodc_tw Pre-Conference Day | April 22 Main Event Days | April 23 & 24 Venue | Boston Convention & Exhibition Center
1
3
129